SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-034943
Filing Date
2012-05-09
Accepted
2012-05-09 12:00:40
Documents
16
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-8876_110q.htm 10-Q 722281
2 EX-10.1 a12-8876_1ex10d1.htm EX-10.1 53293
3 EX-10.2 a12-8876_1ex10d2.htm EX-10.2 79884
4 EX-10.3 a12-8876_1ex10d3.htm EX-10.3 84769
5 EX-10.4 a12-8876_1ex10d4.htm EX-10.4 82435
6 EX-31.1 a12-8876_1ex31d1.htm EX-31.1 11267
7 EX-31.2 a12-8876_1ex31d2.htm EX-31.2 11263
8 EX-32.1 a12-8876_1ex32d1.htm EX-32.1 4999
9 EX-32.2 a12-8876_1ex32d2.htm EX-32.2 4201
16 GRAPHIC g88761kei001.jpg GRAPHIC 4415
  Complete submission text file 0001104659-12-034943.txt   3631858

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT pcrx-20120331.xml EX-101.INS 407732
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20120331.xsd EX-101.SCH 19395
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20120331_cal.xml EX-101.CAL 44767
13 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT pcrx-20120331_lab.xml EX-101.LAB 334804
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20120331_pre.xml EX-101.PRE 156678
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20120331_def.xml EX-101.DEF 104875
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 12824539
SIC: 2834 Pharmaceutical Preparations